{
  "description": "The Mopeia Lassa virus reassortant 29 (ML29) is a genetically engineered virus that was created by reassorting genetic elements from the Mopeia virus and the Lassa virus. The Mopeia virus is a member of the Arenavirus genus, which is known to infect rodents, while the Lassa virus is a human pathogenic arenavirus that can cause severe hemorrhagic fever.\n\nThe ML29 virus was developed as a potential vaccine candidate against Lassa fever, as it retains the immunogenic properties of the Lassa virus while exhibiting reduced virulence and pathogenicity. The reassortment process involves the exchange of genetic segments between the two parent viruses, resulting in a novel virus with a unique genomic composition.\n\nPreliminary studies have shown that the ML29 virus is able to induce a protective immune response in animal models against Lassa fever, without causing the severe clinical manifestations associated with the native Lassa virus. This makes the ML29 virus a promising candidate for further research and development as a safe and effective vaccine against this deadly disease.",
  "model": "claude-3-haiku",
  "prompt": "Provide a short scientific description of this species",
  "dateGenerated": 1749321453529
}